{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:24:47Z","timestamp":1790267087016,"version":"4.1.0"},"reference-count":230,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Pharmacotherapy in the geriatric population is one of the greatest challenges in modern medicine. Elderly patients, characterized by multimorbidity and the resulting polypharmacy, are significantly more exposed to adverse drug reactions (ADRs), which often lead to hospitalization and a decline in quality of life. Understanding the reasons for this difference requires an analysis of the physiological changes that occur during the aging process at the molecular level. This article presents a perspective on the molecular aspects of geriatric pharmacotherapy, focusing on the fundamental mechanisms that are modified with age. The analysis covers changes in pharmacokinetics, including the role and regulation of cytochrome P450 (CYP) enzymes, whose activity, especially in phase I reactions, is significantly reduced. The age-dependent dysfunction of drug transporters from the ABC (ATP-binding cassette) and SLC (solute carrier) families in key organs such as the intestines, liver and kidneys is discussed, which affects the absorption, distribution and elimination of xenobiotic compounds, including drugs. The article also provides a comprehensive analysis of the blood\u2013brain barrier (BBB), describing changes in neurovascular integrity, including the dysfunction of tight junctions and a decrease in the activity of P-glycoprotein, sometimes referred to as multidrug resistance protein (MDR). This increases the susceptibility of the central nervous system to the penetration and action of drugs. In the realm of pharmacodynamics, changes in the density and sensitivity of key receptors (serotonergic, dopaminergic, adrenergic) are described based on neuroimaging data, explaining the molecular basis for increased sensitivity to certain drug classes, such as anticholinergics. The paper also explores new research perspectives, such as the role of the gut microbiome in modulating pharmacokinetics by influencing gene expression and the importance of pharmacoepigenetics, which dynamically regulates drug response throughout life via changes in DNA methylation and histone modifications. The clinical implications of these molecular changes are also discussed, emphasizing the potential of personalized medicine, including pharmacogenomics, in optimizing therapy and minimizing the risk of adverse reactions. Such an integrated approach, incorporating data from multiple fields (genomics, epigenomics, microbiomics) combined with a comprehensive geriatric assessment, appears to be the future of safe and effective pharmacotherapy in the aging population.<\/jats:p>","DOI":"10.3390\/cells14171363","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:39:01Z","timestamp":1756744741000},"page":"1363","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Molecular Aspects of Geriatric Pharmacotherapy"],"prefix":"10.3390","volume":"14","author":[{"given":"Patryk","family":"Rzeczycki","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, 72 Powsta\u0144c\u00f3w Wielkopolskich Avenue, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliwia","family":"P\u0119ciak","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, 72 Powsta\u0144c\u00f3w Wielkopolskich Avenue, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Plust","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, 72 Powsta\u0144c\u00f3w Wielkopolskich Avenue, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6191-7168","authenticated-orcid":false,"given":"Marek","family":"Dro\u017adzik","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, 72 Powsta\u0144c\u00f3w Wielkopolskich Avenue, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1109\/TBME.2003.820359","article-title":"Time-frequency detection and analysis of wheezes during forced exhalation","volume":"51","author":"Fiz","year":"2004","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.anclin.2019.04.007","article-title":"Geriatric Pharmacology: An Update","volume":"37","author":"Andres","year":"2019","journal-title":"Anesthesiol. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10354-021-00903-0","article-title":"Polypharmacy in elderly people","volume":"172","author":"Dovjak","year":"2022","journal-title":"Wien Med. Wochenschr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","article-title":"Adverse outcomes of polypharmacy in older people: Systematic review of reviews","volume":"21","author":"Davies","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0976-500X.110872","article-title":"Adverse drug reactions in the elderly","volume":"4","author":"Brahma","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"ref_6","first-page":"16347","article-title":"Polypharmacy among elderly patients in Poland: Prevalence, predisposing factors, and management strategies","volume":"132","author":"Grodzicki","year":"2022","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Farrell, B., Galley, E., Jeffs, L., Howell, P., and McCarthy, L.M. (2022). \u201cKind of blurry\u201d: Deciphering clues to prevent, investigate and manage prescribing cascades. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0272418"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/0091270007307879","article-title":"A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: The respond trial","volume":"47","author":"Preston","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40266-023-01072-y","article-title":"Prescribing Cascades with Recommendations to Prevent or Reverse Them: A Systematic Review","volume":"40","author":"Adrien","year":"2023","journal-title":"Drugs Aging"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3988\/jcn.2012.8.1.15","article-title":"Drug-induced parkinsonism","volume":"8","author":"Shin","year":"2012","journal-title":"J. Clin. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/JCP.0b013e318268e0d2","article-title":"Parkinsonism in elderly users of haloperidol: Associated with dose, plasma concentration, and duration of use","volume":"32","author":"Knol","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00438-004-1035-3","article-title":"Mapping Ds insertions in barley using a sequence-based approach","volume":"272","author":"Cooper","year":"2004","journal-title":"Mol. Genet. Genom."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4140\/TCP.n.2008.324","article-title":"Pharmacokinetic and pharmacodynamic alterations in the geriatric patient","volume":"23","author":"Delafuente","year":"2008","journal-title":"Consult. Pharm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40262-025-01494-4","article-title":"Influence of Ageing on the Pharmacodynamics and Pharmacokinetics of Chronically Administered Medicines in Geriatric Patients: A Review","volume":"64","author":"Ngcobo","year":"2025","journal-title":"Clin. Pharmacokinet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e14034","DOI":"10.1111\/acel.14034","article-title":"Enabling translational geroscience by broadening the scope of geriatric care","volume":"23","author":"Ferrucci","year":"2024","journal-title":"Aging Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1556\/2060.105.2018.4.32","article-title":"Advances and challenges in geroscience research: An update","volume":"105","author":"Yabluchanskiy","year":"2018","journal-title":"Physiol. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Blasco","year":"2013","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1007\/s11357-023-00873-8","article-title":"The multifaceted benefits of walking for healthy aging: From Blue Zones to molecular mechanisms","volume":"45","author":"Ungvari","year":"2023","journal-title":"Geroscience"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11357-016-9953-7","article-title":"GeroScience: Understanding the interaction of processes of aging and chronic diseases","volume":"38","author":"Sonntag","year":"2016","journal-title":"Age"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tma.2017.09.004","article-title":"Translational geroscience: A new paradigm for 21st century medicine","volume":"1","author":"Kaeberlein","year":"2017","journal-title":"Transl. Med. Aging."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1007\/s00018-012-0962-0","article-title":"Mitochondrial dysfunction and oxidative stress activate inflammasomes: Impact on the aging process and age-related diseases","volume":"69","author":"Salminen","year":"2012","journal-title":"Cell Mol. Life Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/01.mjt.0000183719.84390.4d","article-title":"Pharmacokinetic-pharmacodynamic crisis in the elderly","volume":"14","year":"2007","journal-title":"Am. J. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood-brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discov. Today"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","article-title":"Aging and aging-related diseases: From molecular mechanisms to interventions and treatments","volume":"7","author":"Guo","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Erd\u0151, F., and Krajcsi, P. (2019). Age-Related Functional and Expressional Changes in Efflux Pathways at the Blood-Brain Barrier. Front. Aging Neurosci., 11.","DOI":"10.3389\/fnagi.2019.00196"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1474-9726.2012.00832.x","article-title":"Rapamycin slows aging in mice","volume":"11","author":"Wilkinson","year":"2012","journal-title":"Aging Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e01091","DOI":"10.1002\/prp2.1091","article-title":"Rapamycin treatment increases survival, autophagy biomarkers and expression of the anti-aging klotho protein in elderly mice","volume":"11","author":"Hendrik","year":"2023","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0531-5565(03)00133-5","article-title":"When drug therapy gets old: Pharmacokinetics and pharmacodynamics in the elderly","volume":"38","author":"Turnheim","year":"2003","journal-title":"Exp. Gerontol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-0773.1992.tb00440.x","article-title":"Adipose tissue distribution and chemical structure of basic lipophilic drugs: Desipramine, N-acetyl desipramine, and haloperidol","volume":"70","author":"Moor","year":"1992","journal-title":"Pharmacol. Toxicol."},{"key":"ref_30","unstructured":"Mansoor, A., and Mahabadi, N. (2023). Volume of Distribution. StatPearls, StatPearls Publishing."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3177\/jnsv.53.37","article-title":"Relationship between serum albumin level and aging in community\u2014dwelling elderly persons","volume":"53","author":"Gom","year":"2005","journal-title":"J. Nutr. Sci. Vitaminol"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2125.1998.00842.x","article-title":"Prescribing for the elderly patient: Why do we need to exercise caution?","volume":"46","author":"Hughes","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_33","unstructured":"Rowland, M., and Tozer, T.N. (2010). Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications, Lippincott Williams & Wilkins. [4th ed.]."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.exger.2005.06.009","article-title":"Age-related changes in liver structure and function: Implications for disease?","volume":"40","author":"Schmucker","year":"2005","journal-title":"Exp. Gerontol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1016\/j.bbagen.2012.11.019","article-title":"Glutathione transferases, regulators of cellular metabolism and physiology","volume":"1830","author":"Board","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/tcrm.1.2.151.62914","article-title":"Clinical implications of changes in hepatic drug metabolism in older people","volume":"1","author":"Hilmer","year":"2005","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1472-8206.2007.00473.x","article-title":"Clinical pharmacology in the older person","volume":"21","author":"Hilmer","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bmt.1703016","article-title":"Antithymocyte-associated reticulonodular pneumonitis during a conditioning regimen of reduced intensity for genoidentical bone marrow transplantation","volume":"27","author":"Gratecos","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"ref_41","first-page":"462","article-title":"The role of radiologists in hospitals","volume":"61","author":"Endo","year":"2001","journal-title":"Nihon Igaku Hoshasen Gakkai Zasshi."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0009-9236(97)90166-1","article-title":"Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions","volume":"61","author":"Sotaniemi","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/03602530902843483","article-title":"Polymorphism of human cytochrome P450 enzymes and its clinical impact","volume":"41","author":"Zhou","year":"2009","journal-title":"Drug Metab. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/clpt.2008.302","article-title":"Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics","volume":"85","author":"Morgan","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/mol.109.056705","article-title":"Sex differences in the expression of hepatic drug metabolizing enzymes","volume":"76","author":"Waxman","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1479-7364-4-4-278","article-title":"The human cytochrome P450 (CYP) allele nomenclature website: A peer-reviewed database of CYP variants and their associated effects","volume":"4","author":"Sim","year":"2010","journal-title":"Hum. Genom."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2165\/00003088-200241120-00002","article-title":"Clinical significance of the cytochrome P450 2D6 genetic polymorphism","volume":"41","author":"Desta","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/138920008784220664","article-title":"Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4","volume":"9","author":"Zhou","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2125.2004.02096.x","article-title":"Drug metabolism and ageing","volume":"57","author":"Kinirons","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00004714-200104000-00007","article-title":"Fluoxetine pharmacokinetics and effect on CYP2C19 in young and elderly volunteers","volume":"21","author":"Harvey","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/092986707780090981","article-title":"The Effect of Ageing on Cytochrome P450 Enzymes: Consequences for Drug Biotransformation in the Elderly","volume":"14","author":"Wauthier","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"ref_53","first-page":"1","article-title":"Effects of Pharmacokinetic and Pharmacodynamic Changes in the Elderly","volume":"29","author":"Jacobson","year":"2013","journal-title":"Psychiatr. Times"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2004.06.002","article-title":"Importance of P-glycoprotein at blood-tissue barriers","volume":"25","author":"Fromm","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.cb.08.110192.000435","article-title":"ABC transporters: From microorganisms to man","volume":"8","author":"Higgins","year":"1992","journal-title":"Annu. Rev. Cell. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1023\/A:1012866803188","article-title":"Overview: ABC transporters and human disease","volume":"33","author":"Gottesman","year":"2001","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mam.2012.12.009","article-title":"The ABCs of membrane transporters in health and disease (SLC series): Introduction","volume":"34","author":"Hediger","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","article-title":"Renal transporters in drug development","volume":"53","author":"Morrissey","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.clpt.2006.02.004","article-title":"Effect of age on functional P-glycoprotein in the blood\u2013brain barrier measured by (R)-[11C]verapamil PET","volume":"79","author":"Toornvliet","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/clpt.2008.59","article-title":"Emerging evidence of the impact of kidney disease on drug metabolism and transport","volume":"83","author":"Nolin","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_62","unstructured":"Grogan, S., and Preuss, C.V. (2023). Pharmacokinetics. StatPearls, StatPearls Publishing."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4161\/cbt.4.6.1731","article-title":"Effect of ABCG2 genotype on the oral bioavailability of topotecan","volume":"4","author":"Sparreboom","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd4461","article-title":"What do drug transporters really do?","volume":"14","author":"Nigam","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00003088-200038010-00003","article-title":"Pharmacokinetic\u2013pharmacodynamic consequences and clinical relevance of age-related changes in drug transporters","volume":"38","author":"Dresser","year":"2000","journal-title":"Clin. Pharmacokinet."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1146\/annurev-pharmtox-010617-052713","article-title":"The SLC22 transporter family: A paradigm for the impact of drug transporters on metabolic and signaling pathways, and disease","volume":"58","author":"Nigam","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Nguyen, T., Nguyen, H., and Dang, A. (2020). Determinants of patient satisfaction: Lessons from large-scale inpatient interviews in Vietnam. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239306"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Wada, Y., Inoko, M., Ishihara, K., Fukumoto, K., Tsurudome, Y., Horiguchi, M., Fujimura, A., and Ushijima, K. (2025). Aging reduces ATP-binding cassette transporter expression in brain microvessels of mice. Pharmaceuticals, 18.","DOI":"10.3390\/ph18020191"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev-biochem-060614-033955","article-title":"The biology of proteostasis in aging and disease","volume":"84","author":"Labbadia","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","article-title":"The proteostasis network and its decline in ageing","volume":"20","author":"Hipp","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ckj\/sfw010","article-title":"Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: Potential role of remote sensing and signaling","volume":"9","author":"Bhatnagar","year":"2016","journal-title":"Clin. Kidney J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/mol.110.070607","article-title":"Remote communication through solute carriers and ATP binding cassette drug transporter pathways: An update on the remote sensing and signaling hypothesis","volume":"79","author":"Wu","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"108723","DOI":"10.1016\/j.pharmthera.2024.108723","article-title":"Organic anion transporters in remote sensing and organ crosstalk","volume":"263","author":"Granados","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.ackd.2015.08.004","article-title":"Structural and functional changes with the aging kidney","volume":"23","author":"Denic","year":"2016","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Waas, T., Schulz, A., Lotz, J., Rossmann, H., Pfeiffer, N., Beutel, M.E., Schmidtmann, I., M\u00fcnzel, T., Wild, P.S., and Lackner, K.J. (2021). Distribution of estimated glomerular filtration rate and determinants of its age-dependent loss in a German population-based study. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-89442-7"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1681\/ASN.2015121308","article-title":"Renal aging: Causes and consequences","volume":"28","author":"Hughes","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_78","unstructured":"Katzung, B.G. (2018). Basic & Clinical Pharmacology, McGraw-Hill Education. [14th ed.]."},{"key":"ref_79","unstructured":"Brunton, L.L. (2018). Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics, McGraw-Hill Education. [13th ed.]."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","article-title":"The organic anion transporter (OAT) family: A systems biology perspective","volume":"95","author":"Nigam","year":"2015","journal-title":"Physiol. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/cpt.1516","article-title":"A Comprehensive Analysis of Ontogeny of Renal Drug Transporters: mRNA Analyses, Quantitative Proteomics, and Localization","volume":"106","author":"Cheung","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Zou, W., Shi, B., Zeng, T., Zhang, Y., Huang, B., Ouyang, B., Cai, Z., and Liu, M. (2021). Drug Transporters in the Kidney: Perspectives on Species Differences, Disease Status, and Molecular Docking. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.746208"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1681\/ASN.2009020171","article-title":"Measured GFR as a confirmatory test for estimated GFR","volume":"20","author":"Stevens","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e2234208","DOI":"10.1001\/jamanetworkopen.2022.34208","article-title":"Association of cystatin C kidney function measures with long-term frailty trajectories and physical function decline: A cohort study","volume":"5","author":"Chenglong","year":"2022","journal-title":"JAMA Netw Open"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.mcna.2004.11.009","article-title":"Measurement of kidney function","volume":"89","author":"Stevens","year":"2005","journal-title":"Med. Clin. North. Am."},{"key":"ref_87","first-page":"534","article-title":"Renal function assessment in older adults","volume":"76","author":"Jansen","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/brain\/awr298","article-title":"Blood\u2013brain barrier P glycoprotein function in Alzheimer\u2019s disease","volume":"135","author":"Lubberink","year":"2012","journal-title":"Brain"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s11255-017-1682-z","article-title":"Estimating renal function in old people: An in-depth review","volume":"49","author":"Raman","year":"2017","journal-title":"Int. Urol. Nephrol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2147\/CIA.S313196","article-title":"Drugs Dosing in Geriatric Patients Depending on Kidney Function Estimated by MDRD and Cockroft-Gault Formulas","volume":"16","author":"Ciach","year":"2021","journal-title":"Clin. Interv. Aging"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/1874609810902030187","article-title":"Age-related changes in P-glycoprotein expression in senescence-accelerated mouse","volume":"2","author":"Wu","year":"2009","journal-title":"Curr. Aging Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cpt.409","article-title":"Ontogeny of hepatic drug transporters as quantified by LC-MS\/MS proteomics","volume":"100","author":"Prasad","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/clpt.2014.125","article-title":"The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update","volume":"96","author":"Ramsey","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1111\/bcp.14534","article-title":"Innovative approaches and recent advances in the study of ontogeny of drug metabolism and transport","volume":"88","author":"Allegaert","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1111\/bcp.14821","article-title":"Recent advances in the ontogeny of drug disposition","volume":"88","author":"Chapron","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer\u2019s disease: A matter of blood\u2013brain barrier dysfunction?","volume":"214","author":"Montagne","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the brain vasculature","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Lee, R.-L., and Funk, K.E. (2023). Imaging blood-brain barrier disruption in neuroinflammation and Alzheimer\u2019s disease. Front. Aging Neurosci., 15.","DOI":"10.3389\/fnagi.2023.1144036"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","article-title":"The neurovascular unit coming of age: A journey through neurovascular coupling in health and disease","volume":"96","author":"Iadecola","year":"2017","journal-title":"Neuron"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood\u2013brain barrier to blood\u2013brain interface: New opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41593-019-0434-z","article-title":"Pericyte loss leads to circulatory failure and neurodegeneration in aging","volume":"22","author":"Nikolakopoulou","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/bit.26045","article-title":"Microfluidic blood\u2013brain barrier model provides in vivo-like barrier properties for drug permeability screening","volume":"114","author":"Wang","year":"2017","journal-title":"Biotechnol. Bioeng."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: Production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer\u2019s disease: Current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1177\/0271678X17722436","article-title":"The vascular basement membrane in the healthy and pathological brain","volume":"37","author":"Thomsen","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"166","DOI":"10.18632\/aging.100444","article-title":"Inflammaging: Disturbed interplay between autophagy and inflammasomes","volume":"4","author":"Salminen","year":"2012","journal-title":"Aging"},{"key":"ref_109","first-page":"246","article-title":"Cellular senescence: A new target for neurodegenerative diseases","volume":"16","author":"Meng","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00401-018-1815-1","article-title":"Functional morphology of the blood-brain barrier in health and disease","volume":"135","author":"Liebner","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.201412147","article-title":"Brain barriers: Crosstalk between complex tight junctions and adherens junctions","volume":"209","author":"Tietz","year":"2015","journal-title":"J. Cell Biol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/pr.57.2.4","article-title":"The blood\u2013brain barrier\/neurovascular unit in health and disease","volume":"57","author":"Hawkins","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/157015908785777210","article-title":"Brain endothelial cell-cell junctions: How to \u201copen\u201d the blood brain barrier","volume":"6","author":"Stamatovic","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"ref_115","first-page":"21","article-title":"Aged mice show reduced tight junction protein expression (occludin, ZO-1) in brain capillaries and increased BBB permeability","volume":"12","author":"Elahy","year":"2015","journal-title":"Immun. Ageing"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neurobiolaging.2007.07.015","article-title":"Blood\u2013brain barrier: Ageing and microvascular disease\u2014Systematic review and meta-analysis","volume":"30","author":"Farrall","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1073\/pnas.1300021110","article-title":"Innate immunity receptor CD36 promotes cerebral amyloid angiopathy","volume":"110","author":"Park","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood\u2013brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41586-021-04369-3","article-title":"A human brain vascular atlas reveals diverse mediators of Alzheimer\u2019s risk","volume":"603","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Dithmer, S., Blasig, I.E., Fraser, P.A., Qin, Z., and Haseloff, R.F. (2024). The Basic Requirement of Tight Junction Proteins in Blood-Brain Barrier Function and Their Role in Pathologies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115601"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1523\/JNEUROSCI.6409-11.2012","article-title":"Matrix Metalloproteinase-2-Mediated Occludin Degradation and Caveolin-1-Mediated Claudin-5 Redistribution Contribute to Blood\u2013Brain Barrier Damage in Early Ischemic Stroke Stage","volume":"32","author":"Liu","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.fsi.2016.02.011","article-title":"Immune indices and identical functions of two prophenoloxidases from the haemolymph of green tiger shrimp Penaeus semisulcatus and its antibiofilm activity","volume":"51","author":"Ishwarya","year":"2016","journal-title":"Fish Shellfish Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00228-009-0709-5","article-title":"Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET","volume":"65","author":"Bauer","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s11307-012-0556-0","article-title":"P-glycoprotein function at the blood-brain barrier: Effects of age and gender","volume":"14","author":"Lubberink","year":"2012","journal-title":"Mol. Imaging. Biol."},{"key":"ref_126","first-page":"835","article-title":"Regulation of the multidrug resistance (MDR1) gene expression","volume":"8","author":"Chin","year":"1994","journal-title":"In Vivo"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/cpt.64","article-title":"Regulation of ABC transporters at the blood-brain barrier","volume":"97","author":"Miller","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Chai, A.B., Callaghan, R., and Gelissen, I.C. (2022). Regulation of P-Glycoprotein in the Brain. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232314667"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/153537020523000206","article-title":"Modulation of p-glycoprotein transport function at the blood-brain barrier","volume":"230","author":"Bauer","year":"2005","journal-title":"Exp. Biol. Med."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Shchulkin, A.V., Abalenikhina, Y.V., Kosmachevskaya, O.V., Topunov, A.F., and Yakusheva, E.N. (2024). Regulation of P-Glycoprotein during Oxidative Stress. Antioxidants, 13.","DOI":"10.3390\/antiox13020215"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002512-199101050-00006","article-title":"Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy","volume":"1","author":"Lamy","year":"1991","journal-title":"Drugs Aging"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0749-0690(18)30769-9","article-title":"Pharmacodynamic basis for altered drug action in the elderly","volume":"4","author":"Roberts","year":"1988","journal-title":"Clin. Geriatr. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.amjopharm.2007.10.001","article-title":"Pharmacodynamics in older adults: A review","volume":"5","author":"Bowie","year":"2007","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0021-9681(83)90047-4","article-title":"Aging and drug disposition--pharmacodynamics","volume":"36","author":"Crooks","year":"1983","journal-title":"J. Chronic Dis."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/oxfordjournals.bmb.a072393","article-title":"Pharmacodynamics: Changes in homeostatic mechanisms, receptor and target organ sensitivity in the elderly","volume":"46","author":"Swift","year":"1990","journal-title":"Br. Med. Bull."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2174\/138920011796504473","article-title":"Age-related changes in pharmacodynamics: Focus on drugs acting on central nervous and cardiovascular systems","volume":"12","author":"Spina","year":"2011","journal-title":"Curr. Drug Metab."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0149-7634(02)00065-9","article-title":"Functional imaging studies of dopamine system and cognition in normal aging and Parkinson\u2019s disease","volume":"26","author":"Kaasinen","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"118217","DOI":"10.1016\/j.neuroimage.2021.118217","article-title":"Effect of age on brain metabotropic glutamate receptor subtype 5 measured with [18F]FPEB PET","volume":"238","author":"Mecca","year":"2021","journal-title":"Neuroimage"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0022-3565(25)23569-8","article-title":"Age-related decrease in beta adrenergic receptor\u2013mediated vascular smooth muscle relaxation","volume":"239","author":"Tsujimoto","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/01.RES.0000269183.13937.e8","article-title":"Direct evidence of endothelial oxidative stress with aging in humans: Relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-\u03baB","volume":"100","author":"Donato","year":"2007","journal-title":"Circ. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nri1810","article-title":"Neural regulation of innate immunity: A coordinated nonspecific host response to pathogens","volume":"6","author":"Sternberg","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_142","first-page":"116","article-title":"Beta-adrenergic function in aging. Basic mechanisms and clinical implications","volume":"1","author":"Scarpace","year":"1991","journal-title":"Drugs Aging"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/jcbfm.1993.39","article-title":"Decrease in human striatal dopamine D2 receptor density with age: A PET study with [11C]raclopride","volume":"13","author":"Rinne","year":"1993","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41537-017-0018-4","article-title":"Dopamine D2 receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances","volume":"3","author":"Freyberg","year":"2017","journal-title":"NPJ Schizophr."},{"key":"ref_145","first-page":"346","article-title":"End-Users\u2019 Voice in EHR Selection: Development of a Usability Questionnaire for Demonstrations in Procurement (DPUQ)","volume":"234","author":"Tyllinen","year":"2017","journal-title":"Stud. Health Technol. Inform."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1038\/npp.2011.163","article-title":"Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy population","volume":"36","author":"Price","year":"2011","journal-title":"Neuropsychopharmacol"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0024-3205(02)01745-9","article-title":"Age-related decline of serotonin transporters in living human brain of healthy males","volume":"71","author":"Yamamoto","year":"2002","journal-title":"Life Sci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2019.03.021","article-title":"Reduced serotonin receptors and transporters in normal aging adults: A meta-analysis of PET and SPECT imaging studies","volume":"80","author":"Karrer","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neubiorev.2016.05.008","article-title":"Dysregulated stress signal sensitivity and inflammatory disinhibition as a pathophysiological mechanism of stress-related chronic fatigue","volume":"68","author":"Strahler","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/01.WCB.0000085441.37552.CA","article-title":"Linearized reference tissue parametric imaging methods: Application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain","volume":"23","author":"Ichise","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_151","first-page":"1093","article-title":"Serotonin and brain function: A tale of two receptors","volume":"31","author":"Nutt","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"ref_152","first-page":"741","article-title":"Alzheimer\u2019s Disease: Genes, Proteins, and Therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Phys. Rev."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.npp.1301222","article-title":"Sensorimotor Gating and Dopamine Function in Postpartum Rats","volume":"32","author":"Byrnes","year":"2007","journal-title":"Neuropsychopharmacol"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pneurobio.2009.01.009","article-title":"5-HT1A receptor function in major depressive disorder","volume":"88","author":"Savitz","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/10673220127874","article-title":"Survival and recovery: Psychoanalytic reflections","volume":"9","author":"Ornstein","year":"2001","journal-title":"Harv. Rev. Psychiatry"},{"key":"ref_156","first-page":"145","article-title":"Effect of ATP-sensitive K+ channel blocker (quinine) on the dopamine decrease induced by selective D3 agonist (7-OH-DPAT) in the rat striatum","volume":"21","author":"Shimizu","year":"2001","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1582-4934.2011.01306.x","article-title":"High-molecular weight A\u03b2 oligomers and protofibrils are the predominant A\u03b2 species in the native soluble protein fraction of the AD brain","volume":"16","author":"Upadhaya","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/ard.2007.083584","article-title":"Infliximab efficacy and safety against refractory systemic necrotising vasculitides: Long-term follow-up of 15 patients","volume":"67","author":"Josselin","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneur.1974.00490320001001","article-title":"Human memory and the cholinergic system: A relationship to aging?","volume":"30","author":"Drachman","year":"1974","journal-title":"Arch. Neurol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-clinpsy-050212-185535","article-title":"Neuroimaging and other biomarkers for Alzheimer\u2019s disease: The changing landscape of early detection","volume":"9","author":"Risacher","year":"2013","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","article-title":"The anticholinergic risk scale and anticholinergic adverse effects in older persons","volume":"168","author":"Rudolph","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1002\/mrc.1668","article-title":"Dynamics and structure in the Mn2+ site of concanavalin A as determined by high-field EPR and ENDOR spectroscopy","volume":"43","author":"Goldfarb","year":"2005","journal-title":"Magn. Reson. Chem."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/clpt.2008.224","article-title":"The effects of polypharmacy in older adults","volume":"85","author":"Hilmer","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/092986710790416326","article-title":"Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions","volume":"17","author":"Corsonello","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4037\/ajcc1998.7.3.205","article-title":"Effect of neuromuscular blockers and opiates on the cerebrovascular response to endotracheal suctioning in adults with severe head injuries","volume":"7","author":"Kerr","year":"1998","journal-title":"Am. J. Crit. Care."},{"key":"ref_166","first-page":"16","article-title":"Examination related to revised test method for determination of formaldehyde, regulated by the law for the control of household products containing harmful substances","volume":"121","author":"Ikarashi","year":"2003","journal-title":"Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0031-6997(24)01340-1","article-title":"Role of pharmacokinetics and metabolism in drug discovery and development","volume":"9","author":"Lin","year":"1997","journal-title":"Pharmacol. Rev."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCRESAHA.113.301384","article-title":"Lineage of bone marrow-derived cells in atherosclerosis","volume":"112","author":"Iwata","year":"2013","journal-title":"Circ. Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e468-95","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: A scientific statement from the American Heart Association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/geno.1998.5279","article-title":"Tissue-specific expression and mapping of the Cox7ah gene in mouse","volume":"49","author":"Jaradat","year":"1998","journal-title":"Genomics"},{"key":"ref_171","first-page":"237","article-title":"Les infections urinaires de l\u2019enfant","volume":"54","author":"Bensman","year":"2004","journal-title":"Rev Prat."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.410330214","article-title":"Signal loss in the motor cortex on magnetic resonance images in amyotrophic lateral sclerosis","volume":"33","author":"Ishikawa","year":"1993","journal-title":"Ann. Neurol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pneurobio.2005.04.006","article-title":"Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases","volume":"76","author":"Potschka","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/pr.118.015578","article-title":"Organic cation transporters in health and disease","volume":"72","author":"Koepsell","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.20130901","article-title":"IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo","volume":"211","author":"Xue","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_176","first-page":"11","article-title":"Anticholinergic effects of medication in elderly patients","volume":"62","author":"Tune","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"ref_177","first-page":"395","article-title":"Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review","volume":"18","author":"Beakley","year":"2015","journal-title":"Pain Physician"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/ejhpharm-2015-000838","article-title":"Interaction between tramadol and selective serotonin reuptake inhibitors: Are doctors aware of potential risks in their prescription practice?","volume":"24","author":"Spies","year":"2020","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/17512433.2014.910111","article-title":"Understanding and preventing drug\u2013drug and drug\u2013gene interactions","volume":"7","author":"Tannenbaum","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","article-title":"Polypharmacy in elderly patients","volume":"5","author":"Hajjar","year":"2007","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_181","unstructured":"Katzung, B.G., and Trevor, A.J. (2021). Basic and Clinical Pharmacology, McGraw-Hill Education. [15th ed.]."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3748\/wjg.v22.i1.361","article-title":"Gut microbiota in autism and mood disorders","volume":"22","author":"Mangiola","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"10419","DOI":"10.1080\/10408398.2023.2224867","article-title":"Gut microbiota and anti-aging: Focusing on spermidine","volume":"64","author":"Yu","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nature11319","article-title":"Gut microbiota composition correlates with diet and health in the elderly","volume":"488","author":"Claesson","year":"2012","journal-title":"Nature"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11357-011-9217-5","article-title":"Ageing of the human metaorganism: The microbial counterpart","volume":"34","author":"Biagi","year":"2012","journal-title":"Age"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e01993-22","DOI":"10.1128\/mbio.01993-22","article-title":"Microbial metabolites orchestrate a distinct multi-tiered regulatory network in the intestinal epithelium that directs P-glycoprotein expression","volume":"13","author":"Foley","year":"2022","journal-title":"mBio"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.trsl.2016.08.002","article-title":"Gut microbiome interactions with drug metabolism, efficacy, and toxicity","volume":"179","author":"Wilson","year":"2017","journal-title":"Transl. Res."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrmicro.2016.17","article-title":"The microbial pharmacists within us: A metagenomic view of xenobiotic metabolism","volume":"14","author":"Spanogiannopoulos","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phrs.2012.10.005","article-title":"Aging and gut microbes: Perspectives for health maintenance and longevity","volume":"69","author":"Biagi","year":"2013","journal-title":"Pharmacol. Res."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez-Baeza, Y., Hyde, E.R., Suchodolski, J.S., and Knight, R. (2016). Dog and human inflammatory bowel disease rely on overlapping yet distict dysbiosis networks. Nat. Microbiol., 1.","DOI":"10.1038\/nmicrobiol.2016.177"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrmicro2536","article-title":"Finlay BB. Shifting the balance: Antibiotic effects on host-microbiota mutualism","volume":"9","author":"Willing","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"20115","DOI":"10.2807\/ese.17.11.20115-en","article-title":"Moderate influenza vaccine effectiveness in Victoria, Australia, 2011","volume":"17","author":"Fielding","year":"2012","journal-title":"Euro. Surveill."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Markowiak, P., and \u015ali\u017cewska, K. (2017). Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients, 9.","DOI":"10.3390\/nu9091021"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mrm.25659","article-title":"An efficient calculation method for pharmacokinetic parameters in brain permeability study using dynamic contrast-enhanced MRI","volume":"75","author":"Wang","year":"2016","journal-title":"Magn. Reson. Med."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2015.08.015","article-title":"The genetics of human autoimmune disease: A perspective on progress in the field and future directions","volume":"64","author":"Seldin","year":"2015","journal-title":"J. Autoimmun."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.fct.2013.05.055","article-title":"Hepatoprotective activity of puerarin against carbon tetrachloride-induced injuries in rats: A randomized controlled trial","volume":"59","author":"Xia","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.apsb.2015.01.007","article-title":"Epigenetic regulation of drug metabolism and transport","volume":"5","author":"Peng","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ajog.2013.05.011","article-title":"Planned home birth: The professional responsibility response--a midwifery response","volume":"209","author":"Dixon","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/s41467-019-10461-0","article-title":"Integrated analysis of environmental and genetic influences on cord blood DNA methylation in new-borns","volume":"10","author":"Czamara","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1073\/pnas.1520665113","article-title":"A topologically driven glass in ring polymers","volume":"113","author":"Michieletto","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-0043-117268","article-title":"Animal-Naming-Test\u2014Tiere als diagnostischer Ausweg?","volume":"56","author":"Labenz","year":"2018","journal-title":"Z. Gastroenterol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2012.10.016","article-title":"Genome-wide methylation profiles reveal quantitative views of human aging rates","volume":"49","author":"Hannum","year":"2013","journal-title":"Mol. Cell."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dss.2004.09.007","article-title":"Mining association rules with multiple minimum supports: A new mining algorithm and a support tuning mechanism","volume":"42","author":"Hu","year":"2006","journal-title":"Decis. Support. Syst."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"e13089","DOI":"10.14814\/phy2.13089","article-title":"Impaired myogenic response of the afferent arteriole contributes to the increased susceptibility to renal disease in Milan normotensive rats","volume":"5","author":"Ge","year":"2017","journal-title":"Physiol. Rep."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/ejn.14536","article-title":"The ventrolateral periaqueductal grey updates fear via positive prediction error","volume":"51","author":"Walker","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"8446","DOI":"10.1039\/c3dt50283j","article-title":"Relative kinetic reactivity of boronic acid and boronate ion towards Tiron, 2,2\u2019-biphenol, and propylene glycol","volume":"42","author":"Watanabe","year":"2013","journal-title":"Dalton Trans."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1126\/science.aap9516","article-title":"A global atlas of the dominant bacteria found in soil","volume":"359","author":"Oliverio","year":"2018","journal-title":"Science"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"573","DOI":"10.18632\/aging.101414","article-title":"An epigenetic biomarker of aging for lifespan and healthspan","volume":"10","author":"Levine","year":"2018","journal-title":"Aging"},{"key":"ref_210","first-page":"1220","article-title":"Eleven telomere, epigenetic clock, and biomarker-composite quantifications of biological aging: Do they measure the same thing?","volume":"187","author":"Belsky","year":"2018","journal-title":"Am. J. Epidemiol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/cpt.2526","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update","volume":"112","author":"Lee","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cpt.2149","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy","volume":"110","author":"Crews","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cpt.668","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update","volume":"102","author":"Johnson","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/clpt.2013.229","article-title":"Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing","volume":"95","author":"Shi","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Samwald, M., Xu, H., Blagec, K., Empey, P.E., Malone, D.C., Ahmed, S.M., Hofer, S., and Boyce, R.D. (2016). Incidence of exposure of patients in the United States to multiple drugs for which pharmacogenomic guidelines are available. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164972"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nature09587","article-title":"Subtypes of medulloblastoma have distinct developmental origins","volume":"468","author":"Gibson","year":"2010","journal-title":"Nature"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cpt.147","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors","volume":"98","author":"Hicks","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/clpt.2013.105","article-title":"Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update","volume":"94","author":"Scott","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/clpt.2013.254","article-title":"Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2D6 Genotype and Codeine Therapy: 2014 Update","volume":"95","author":"Crews","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/clpt.2011.185","article-title":"Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing","volume":"90","author":"Johnson","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/cpt.630","article-title":"The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and metrics of pharmacogenetic implementations across diverse healthcare systems","volume":"102","author":"Luzum","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_222","first-page":"24","article-title":"PROTACs technology for treatment of Alzheimer\u2019s disease: Advances and perspectives","volume":"1","author":"Inuzuka","year":"2022","journal-title":"Acta Mater. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"10","DOI":"10.36469\/jheor.2021.19008","article-title":"Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons","volume":"8","author":"Tremblay","year":"2021","journal-title":"J. Health Econ. Outcomes Res."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature15817","article-title":"Pharmacogenomics in the clinic","volume":"526","author":"Relling","year":"2015","journal-title":"Nature"},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Horvath, S. (2013). DNA methylation age of human tissues and cell types. Genome Biol., 14.","DOI":"10.1186\/gb-2013-14-10-r115"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/acel.12386","article-title":"Integration of \u2018omics\u2019 data in aging research: From biomarkers to systems biology","volume":"14","author":"Zierer","year":"2015","journal-title":"Aging Cell"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1109\/TBME.2020.3024632","article-title":"An Optimization-Based Algorithm for Trajectory Planning of an Under-Actuated Robotic Arm to Perform Autonomous Suturing","volume":"68","author":"Dehghani","year":"2021","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1130\/G45793.1","article-title":"Boundary condition controls on the high-sand-flux regions of Mars","volume":"47","author":"Chojnacki","year":"2019","journal-title":"Geology"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","article-title":"DNA methylation-based biomarkers and the epigenetic clock theory of ageing","volume":"19","author":"Horvath","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"EBioMedicine"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1363\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:37:29Z","timestamp":1760035049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":230,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cells14171363"],"URL":"https:\/\/doi.org\/10.3390\/cells14171363","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]}}}